Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Clinical and Experimental Dermatology
|
February 21, 2006
Analysis of GM-CSF gene polymorphisms (3606T/C and 3928C/T) in Japanese patients with atopic dermatitis
H Saeki, Y Tsunemi, N Asano, et al.
Blood
|
April 6, 2001
Stat5a regulates T helper cell differentiation by several distinct mechanisms
S Kagami, H Nakajima, A Suto, et al.
Histology and Histopathology
|
March 16, 2012
Prognostic significance of BAF57 expression in patients with endometrial carcinoma
S Kagami, T Kurita, T Kawagoe, et al.
Bone Marrow Transplantation
|
February 21, 2006
Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor
H Watanabe, T Watanabe, H Suzuya, et al.
Clinical and Experimental Dermatology
|
February 20, 2007
Sézary syndrome treated with narrowband ultraviolet B: time-course measurement of serum levels of CCL17/CCL27
Y Masui, M Sugaya, S Kagami, et al.
Cancer Gene Therapy
|
September 17, 2011
D-amino acid oxidase gene therapy sensitizes glioma cells to the antiglycolytic effect of 3-bromopyruvate
S M El Sayed, R M Abou El-Magd, Y Shishido, et al.
Clinical and Experimental Dermatology
|
June 1, 2011
High levels of LIGHT and low levels of soluble herpesvirus entry mediator in sera of patients with atopic dermatitis
S Morimura, M Sugaya, H Kai, et al.
Journal of Bioenergetics and Biomembranes
|
February 10, 2012
3-Bromopyruvate antagonizes effects of lactate and pyruvate, synergizes with citrate and exerts novel anti-glioma effects
S M El Sayed, R M Abou El-Magd, Y Shishido, et al.
Clinical and Experimental Immunology
|
November 18, 2003
Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxin-3/CCL26 levels reflect the disease activity of atopic dermatitis
S Kagami, T Kakinuma, H Saeki, et al.
Journal of Dermatological Science
|
January 2, 2009
Increased CCL1 levels in the sera and blister fluid of patients with bullous pemphigoid
T Miyagaki, M Sugaya, S Kagami, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Clinical and Experimental Dermatology
|
February 21, 2006
Analysis of GM-CSF gene polymorphisms (3606T/C and 3928C/T) in Japanese patients with atopic dermatitis
H Saeki, Y Tsunemi, N Asano, et al.
Blood
|
April 6, 2001
Stat5a regulates T helper cell differentiation by several distinct mechanisms
S Kagami, H Nakajima, A Suto, et al.
Histology and Histopathology
|
March 16, 2012
Prognostic significance of BAF57 expression in patients with endometrial carcinoma
S Kagami, T Kurita, T Kawagoe, et al.
Bone Marrow Transplantation
|
February 21, 2006
Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor
H Watanabe, T Watanabe, H Suzuya, et al.
Clinical and Experimental Dermatology
|
February 20, 2007
Sézary syndrome treated with narrowband ultraviolet B: time-course measurement of serum levels of CCL17/CCL27
Y Masui, M Sugaya, S Kagami, et al.
Cancer Gene Therapy
|
September 17, 2011
D-amino acid oxidase gene therapy sensitizes glioma cells to the antiglycolytic effect of 3-bromopyruvate
S M El Sayed, R M Abou El-Magd, Y Shishido, et al.
Clinical and Experimental Dermatology
|
June 1, 2011
High levels of LIGHT and low levels of soluble herpesvirus entry mediator in sera of patients with atopic dermatitis
S Morimura, M Sugaya, H Kai, et al.
Journal of Bioenergetics and Biomembranes
|
February 10, 2012
3-Bromopyruvate antagonizes effects of lactate and pyruvate, synergizes with citrate and exerts novel anti-glioma effects
S M El Sayed, R M Abou El-Magd, Y Shishido, et al.
Clinical and Experimental Immunology
|
November 18, 2003
Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxin-3/CCL26 levels reflect the disease activity of atopic dermatitis
S Kagami, T Kakinuma, H Saeki, et al.
Journal of Dermatological Science
|
January 2, 2009
Increased CCL1 levels in the sera and blister fluid of patients with bullous pemphigoid
T Miyagaki, M Sugaya, S Kagami, et al.
Page
of 8